FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $3.33, $0.16 better than the analyst estimate of $3.17. Revenue for the quarter came in at $2.67 billion versus the consensus estimate of $2.66 billion.
GUIDANCE:
Quest Diagnostics sees FY2022 EPS of $8.65-$9.35, versus the consensus of... More

